ClinicalTrials.Veeva

Menu

ACT and Virtual Reality for Public Speaking Fear

E

European University

Status

Completed

Conditions

Public Speaking Fear

Treatments

Behavioral: Virtual Reality
Behavioral: ACT
Behavioral: In vivo exposure:

Study type

Interventional

Funder types

Other

Identifiers

NCT05573620
CIPI/19/052

Details and patient eligibility

About

Investigation of Acceptance and Commitment Therapy (ACT) for the psychological treatment of public speaking fear. Two ACT-based treatment delivery modalities (in vivo exposure vs. virtual reality) were compared.

Full description

After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry.

The clinical trial will include a control group (waiting list).

Patients who meet eligibility requirements will be assigned to a waiting list, in vivo exposure and Virtual Reality.

Psychological intervention consisted in a 5-session individual face-to-face delivered ACT-based treatment.

The participants will be assessed through self-report instruments and observational measurements before and after treatment and at 3 months follow-up.

Enrollment

37 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Student at European University of Madrid, Spain
  • Significant social anxiety (LSAS Liebowitz Social Anxiety Scale)
  • Subjective fear intensity and interference > 5/10

Exclusion criteria

  • Alcohol or drugs abuse
  • Psychotropic drug consume
  • Following psychological/psychiatric treatment
  • Serious mental disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

37 participants in 3 patient groups

ACT+In vivo exposure
Experimental group
Description:
5 individual weekly sessions which included ACT methods + in vivo exposure
Treatment:
Behavioral: In vivo exposure:
Behavioral: ACT
ACT+Virtual reality
Experimental group
Description:
5 individual weekly sessions which included ACT methods + virtual reality
Treatment:
Behavioral: Virtual Reality
Behavioral: ACT
Waiting list
No Intervention group
Description:
Participants assigned to Waiting List arm waited for 5 weeks before receiving treatment (i.e., after completing the measures they continued in the study and then were randomly assigned to ACT+in vivo exposure or ACT+virtual reality arms).

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems